BOSTON, Oct. 3, 2018 /PRNewswire/ -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representinginvestors nationwide, is investigating whether Nektar Therapeutics ("Nektar" or the "Company") (NASDAQ: NKTR) and certain of its officers and directors violated federal securities laws.
On October 1, 2018, Plainview LLC ("Plainview") published
Following this report, the Company's stock price plunged more than 11% over the next two days.
If you purchased or otherwise acquired Nektar securities and have questions about your legal rights, or possess information relevant to this investigation, you are encouraged to contact attorney John DeFelice at (888) 868-2385, by email at firstname.lastname@example.org or by visiting http://shareholder.law/nektar.
Block & Leviton LLP was recently ranked 4th among securities litigation firms by ISS for recoveries in 2017. The firm represents many of the nation's largest institutional investors and numerous individual investors in securities litigation throughout the country. Indeed, its lawyers have recovered billions of dollars for its clients.
This notice may constitute attorney advertising.
BLOCK & LEVITON LLPJohn DeFelice(617) 398-5600 phone155 Federal Street, Suite 400Boston, MA email@example.com
View original content:http://www.prnewswire.com/news-releases/nektar-therapeutics-nktr-investigated-by-block--leviton-llp-for-violations-of-federal-securities-laws-300724117.html
SOURCE Block & Leviton LLP
Subscribe to our Free Newsletters!